Related Experiment Video
Updated: Jul 11, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cells
Bernhard H Rauch1, Birgit Müschenborn, Marina Braun
1Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum, Düsseldorf, Universitätsstr. 1, 40225 Düsseldorf, Germany.
Abstract:
Fibrinogen deposition in the vessel wall represents an independent atherogenic risk factor. In Boyden-chamber assays, fibrinogen concentration-dependently (1-100 microM) induced migration of human vascular smooth muscle cells (SMC). This was inhibited by antibodies to intercellular adhesion molecule-1 (ICAM-1, 10 microg/ml), and by inhibitors of PI3-kinase (LY294002, 10 microM) and MAPK (mitogen-activated protein kinase) p38 (SB203580, 10 microM). The MEK (MAP kinase kinase) inhibitor PD98059 (10 muM) and the GPIIb/IIIa antagonist abciximab (10 mug/ml) had no effect. ICAM-1 antibodies inhibited fibrinogen-induced Akt and p38 phosphorylation. Thus fibrinogen stimulates human SMC migration through binding to ICAM-1 and activation of Akt and p38.
Insights
Fibrinogen in vessel walls drives smooth muscle cell migration via intercellular adhesion molecule-1 (ICAM-1). This process involves activating PI3-kinase/Akt and MAPK p38 pathways, crucial for atherosclerosis development.
Area of Science:
- Cardiovascular Biology
- Atherosclerosis Research
- Cellular Signaling
Background:
- Vessel wall fibrinogen deposition is an independent risk factor for atherosclerosis.
- Understanding the mechanisms of smooth muscle cell (SMC) migration is critical for preventing vascular disease.
Purpose of the Study:
- To investigate the role of fibrinogen in inducing human vascular SMC migration.
- To elucidate the molecular pathways and adhesion molecules involved in fibrinogen-mediated SMC migration.
Main Methods:
- Boyden-chamber assays were used to measure human vascular SMC migration.
- Experiments involved varying fibrinogen concentrations and utilizing specific inhibitors and antibodies.
- Western blotting was employed to assess protein phosphorylation, including Akt and p38.
Main Results:
- Fibrinogen dose-dependently induced human SMC migration.
- Migration was inhibited by antibodies against intercellular adhesion molecule-1 (ICAM-1) and by PI3-kinase and p38 MAPK inhibitors.
- ICAM-1 antibody treatment blocked fibrinogen-induced phosphorylation of Akt and p38.
Conclusions:
- Fibrinogen stimulates human SMC migration by binding to ICAM-1.
- This interaction activates the PI3-kinase/Akt and p38 MAPK signaling pathways.
- Targeting the fibrinogen-ICAM-1 interaction may offer a therapeutic strategy for atherosclerosis.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Overview of Cell-Matrix Interactions

